BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37878023)

  • 1. Treg plasticity and human diseases.
    Zhang Z; Guo J; Jia R
    Inflamm Res; 2023 Dec; 72(12):2181-2197. PubMed ID: 37878023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.
    Qiu R; Zhou L; Ma Y; Zhou L; Liang T; Shi L; Long J; Yuan D
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):52-70. PubMed ID: 30449014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative transcriptome analysis reveals distinct genetic modules associated with Helios expression in intratumoral regulatory T cells.
    Yates K; Bi K; Haining WN; Cantor H; Kim HJ
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2162-2167. PubMed ID: 29440380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxP3
    Saleh R; Elkord E
    Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis.
    Almanzar G; Klein M; Schmalzing M; Hilligardt D; El Hajj N; Kneitz H; Wild V; Rosenwald A; Benoit S; Hamm H; Tony HP; Haaf T; Goebeler M; Prelog M
    Int Arch Allergy Immunol; 2016; 171(2):141-154. PubMed ID: 27902985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Providence of the CD25
    Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
    Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
    Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
    J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo.
    Giri PS; Mistry J; Dwivedi M
    J Immunol Res; 2022; 2022():6952299. PubMed ID: 36164321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity.
    Whiteside TL
    Expert Opin Ther Targets; 2018 Apr; 22(4):353-363. PubMed ID: 29532697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSF1 promotes CD69
    Yu L; Zhou B; Zhu Y; Li L; Zhong Y; Zhu L; Wang H; Chen H; Xu J; Guo T; Feng L; Wang X; Cai Z; Wang J; Jin H
    Theranostics; 2023; 13(6):1892-1905. PubMed ID: 37064870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood.
    Wang T; Sun X; Zhao J; Zhang J; Zhu H; Li C; Gao N; Jia Y; Xu D; Huang FP; Li N; Lu L; Li ZG
    Ann Rheum Dis; 2015 Jun; 74(6):1293-301. PubMed ID: 24521740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of stable human FOXP3
    Cook L; Reid KT; Häkkinen E; de Bie B; Tanaka S; Smyth DJ; White MP; Wong MQ; Huang Q; Gillies JK; Ziegler SF; Maizels RM; Levings MK
    Immunol Cell Biol; 2021 Sep; 99(8):833-847. PubMed ID: 33929751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of Helios in Foxp3
    Yu WQ; Ji NF; Gu CJ; Wang YL; Huang M; Zhang MS
    Dis Markers; 2021; 2021():5574472. PubMed ID: 34257746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remodeling of the tumor microenvironment via disrupting Blimp1
    Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
    Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP3/HAT1 Axis Controls Treg Infiltration in the Tumor Microenvironment by Inducing CCR4 Expression in Breast Cancer.
    Sarkar T; Dhar S; Chakraborty D; Pati S; Bose S; Panda AK; Basak U; Chakraborty S; Mukherjee S; Guin A; Jana K; Sarkar DK; Sa G
    Front Immunol; 2022; 13():740588. PubMed ID: 35222362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T Cell Stability and Plasticity in Atherosclerosis.
    Ali AJ; Makings J; Ley K
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point?
    Liu J; Zhang B; Zhang G; Shang D
    Front Immunol; 2024; 15():1345838. PubMed ID: 38449875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy.
    Miyabe C; Miyabe Y; Strle K; Kim ND; Stone JH; Luster AD; Unizony S
    Ann Rheum Dis; 2017 May; 76(5):898-905. PubMed ID: 27927642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles.
    Sahin E; Sahin M
    J Immunother; 2019 Jan; 42(1):11-22. PubMed ID: 30407230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection of human regulatory T cells downregulates Foxp3 expression by increasing DNMT3b levels and DNA methylation in the FOXP3 gene.
    Pion M; Jaramillo-Ruiz D; Martínez A; Muñoz-Fernández MA; Correa-Rocha R
    AIDS; 2013 Aug; 27(13):2019-29. PubMed ID: 24201117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.